Publications by authors named "Sandra WeiSSmann"

Claim this Profile
P
Primary asciminib resistance in a chronic myeloid leukemia patient with the atypical BCR::ABL1 e13a3 transcript: a case study.
Birte Kristin Jung, Sandra Weißmann, Caroline Schock, Manja Meggendorfer, Torsten Haferlach

Haematologica· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical meets malignant hematology: a case of acquired εγδβ-thalassemia in clonal hematopoiesis.
Armin P Piehler, Marietta Truger, Jan-Hendrik Kozik, Sandra Weissmann, Martin Schwonzen

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
Calogero Vetro, Torsten Haferlach, Sabine Jeromin, Anna Stengel, Melanie Zenger, Sandra Weissmann

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.
Sabine Jeromin, Torsten Haferlach, Sandra Weissmann, Manja Meggendorfer, Christiane Eder

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia.
Marietta S Truger, Sabine Jeromin, Sandra Weissmann, Frank Dicker, Wolfgang Kern

Br J Haematol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.
Anna Stengel, Susanne Schnittger, Sandra Weissmann, Sabrina Kuznia, Wolfgang Kern

Blood· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
Verena Mühlbacher, Melanie Zenger, Susanne Schnittger, Sandra Weissmann, Franziska Kunze

Genes Chromosomes Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness of amplicon deep sequencing underlines its utility in clinical applications.
Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann, Wolfgang Kern

J Mol Diagn· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.
Vera Grossmann, Claudia Haferlach, Niroshan Nadarajah, Annette Fasan, Sandra Weissmann

Br J Haematol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
Vera Grossmann, Claudia Haferlach, Sandra Weissmann, Andreas Roller, Sonja Schindela

Genes Chromosomes Cancer· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.
Ulrike Bacher, Sandra Weissmann, Alexander Kohlmann, Sonja Schindela, Tamara Alpermann

Br J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis